Published 3 days ago • loading... • Updated 2 days ago

Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth

Summary by The Daily News

SYDNEY--(BUSINESS WIRE)--Mar 30, 2025-

8 Articles

All

Left

Center

Right

The Straits Times

Lean Right

Temasek, GIC said to buy stake in clinical tester Novotech at $2.5 billion valuation

Since TPG’s investment in 2017, the firm has raised its headcount tenfold to 3,000 employees and expanded its operations globally.

3 days ago·Singapore

Read Full Article

The Daily News

Reposted by

The AI Journal

Lean Right

Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth

SYDNEY--(BUSINESS WIRE)--Mar 30, 2025-

3 days ago

Read Full Article

Australian Financial Review

Lean Right

TPG Capital seals $3b-plus Novotech sale with Singapore’s GIC, Temasek

The two sovereign wealth funds have taken a “significant stake” in the clinical research business owned by the private equity giant for eight years.

3 days ago·Sydney, Australia

Read Full Article

Bloomberg

Lean Left

Temasek, GIC Are Said to Buy Novotech Stake in Deal With TPG

Temasek Holdings Pte and GIC Pte Ltd. will acquire a significant stake in Novotech Pty Ltd. to fuel growth and accelerate acquisitions for the clinical research and testing provider, valuing the company at about A$3 billion ($1.9 billion), people familiar with the matter said.

3 days ago·United States

Read Full Article

TechNode Global

Temasek and GIC acquire stake in Singapore-headquartered biotech specialist CRO Novotech

Novotech, Singapore-headquartered full-service biotech specialist clinical research organization (CRO), announced that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth. Existing investor TPG will also reinvest through its TPG Asia fund, Novotech said in a statement on last Sunday. According to the statement, the reinve…

2 days ago

Read Full Article

FinSMEs

Novotech Receives Investment From GIC, Temasek, and TPG

Novotech, a Sydney, Australia-based biotech specialist clinical research organization (CRO), received an investment from GIC, Teasek and TPG. The amount of the deal was not disclosed. The company intends to use the funds to accelerate its growth and pursue M&A opportunities. Led by CEO John Moller, Novotech is a full-service clinical research organization (CRO) and […] The post Novotech Receives Investment From GIC, Temasek, and TPG appeared fir…

3 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year